Royston L, Essaidi-Laziosi M, Perez-Rodriguez F, Piuz I, Geiser J, Krause K
PLoS Pathog. 2018; 14(4):e1006962.
PMID: 29630666
PMC: 5908207.
DOI: 10.1371/journal.ppat.1006962.
Fuchs R, Blaas D
Adv Virol. 2012; 2012:826301.
PMID: 23227049
PMC: 3513715.
DOI: 10.1155/2012/826301.
Bilek G, Matscheko N, Pickl-Herk A, Weiss V, Subirats X, Kenndler E
J Virol. 2011; 85(16):8368-75.
PMID: 21680510
PMC: 3147984.
DOI: 10.1128/JVI.00329-11.
Hewat E, Blaas D
J Virol. 2006; 80(24):12398-401.
PMID: 17005641
PMC: 1676314.
DOI: 10.1128/JVI.01399-06.
Walukiewicz H, Johnson J, Schneemann A
J Virol. 2005; 80(2):615-22.
PMID: 16378964
PMC: 1346855.
DOI: 10.1128/JVI.80.2.615-622.2006.
A cellular receptor of human rhinovirus type 2, the very-low-density lipoprotein receptor, binds to two neighboring proteins of the viral capsid.
Neumann E, Moser R, Snyers L, Blaas D, Hewat E
J Virol. 2003; 77(15):8504-11.
PMID: 12857919
PMC: 165241.
DOI: 10.1128/jvi.77.15.8504-8511.2003.
Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination.
Vlasak M, Blomqvist S, Hovi T, Hewat E, Blaas D
J Virol. 2003; 77(12):6923-30.
PMID: 12768011
PMC: 156168.
DOI: 10.1128/jvi.77.12.6923-6930.2003.
Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH.
Brabec M, Baravalle G, Blaas D, Fuchs R
J Virol. 2003; 77(9):5370-7.
PMID: 12692239
PMC: 153956.
DOI: 10.1128/jvi.77.9.5370-5377.2003.
Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection.
Bayer N, Schober D, Prchla E, Murphy R, Blaas D, Fuchs R
J Virol. 1998; 72(12):9645-55.
PMID: 9811698
PMC: 110474.
DOI: 10.1128/JVI.72.12.9645-9655.1998.
WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
Shepard D, Heinz B, Rueckert R
J Virol. 1993; 67(4):2245-54.
PMID: 8383239
PMC: 240355.
DOI: 10.1128/JVI.67.4.2245-2254.1993.
Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.
Greve J
J Virol. 1993; 67(1):390-7.
PMID: 8093221
PMC: 237375.
DOI: 10.1128/JVI.67.1.390-397.1993.
Comparison of in vitro and cell-mediated alteration of a human Rhinovirus and its inhibition by sodium dodecyl sulfate.
LONBERG-HOLM K
J Virol. 1973; 12(4):819-26.
PMID: 4359954
PMC: 356699.
DOI: 10.1128/JVI.12.4.819-826.1973.
Antigenic determinants of infective and inactivated human rhinovirus type 2.
LONBERG-HOLM K, Yin F
J Virol. 1973; 12(1):114-23.
PMID: 4126195
PMC: 355237.
DOI: 10.1128/JVI.12.1.114-123.1973.
Lack of close relationship between three strains of human rhinoviruses as determined by their RNA sequences.
Yin F, LONBERG-HOLM K, Chan S
J Virol. 1973; 12(1):108-13.
PMID: 4126194
PMC: 355236.
DOI: 10.1128/JVI.12.1.108-113.1973.
Characterization of human rhinoviruses displaced by an anti-receptor monoclonal antibody.
Abraham G, Colonno R
J Virol. 1988; 62(7):2300-6.
PMID: 2836613
PMC: 253381.
DOI: 10.1128/JVI.62.7.2300-2306.1988.
Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.
Fricks C, Hogle J
J Virol. 1990; 64(5):1934-45.
PMID: 2157861
PMC: 249347.
DOI: 10.1128/JVI.64.5.1934-1945.1990.
Properties and origins of infectious rhinovirus type 14 particles of different buoyant densities.
Gauntt C, Griffith M, Sauck J, Upson R, CARLSON E
J Virol. 1975; 16(5):1265-72.
PMID: 171453
PMC: 355726.
DOI: 10.1128/JVI.16.5.1265-1272.1975.
Alteration of capsid proteins of coxsackievirus A13 by low ionic concentrations.
CORDS C, JAMES C, McLaren L
J Virol. 1975; 15(2):244-52.
PMID: 163352
PMC: 354446.
DOI: 10.1128/JVI.15.2.244-252.1975.
Replication of rhinoviruses.
Butterworth B, Grunert R, Korant B, LONBERG-HOLM K, Yin F
Arch Virol. 1976; 51(3):169-89.
PMID: 61746
DOI: 10.1007/BF01318022.
Survival of coxsackievirus B3 under diverse environmental conditions.
McGeady M, Siak J, CROWELL R
Appl Environ Microbiol. 1979; 37(5):972-7.
PMID: 39495
PMC: 243334.
DOI: 10.1128/aem.37.5.972-977.1979.
